A2M and Sepsis: To validate our findings, we extended the number of plasma samples for trauma (n = 23) and sepsis patients (n = 23) and performed quantitative ELISA to measure the contents of A2M, IL1F10, SYT13, and TREM1 in these samples at three time points (day 0, 3 and 5).